Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | STAT3 | P40763 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | TAS2R46 | P59540 | 4/20 | 0.31 |
| ▸ | TAS2R31 | P59538 | 2/20 | 0.31 |
| ▸ | TAS2R10 | Q9NYW0 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15012441 | 1.00 | LMNA (0.42) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL15012463 | 1.00 | LMNA (0.42) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL10532824 | 1.00 | LMNA (0.42) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL15012464 | 1.00 | LMNA (0.42) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL295446 | 0.86 | LMNA (0.40) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL16053147 | 0.86 | LMNA (0.40) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| Chloroxylenol SCHEMBL16266545 | 0.84 | CYP3A4 (0.42) | LMNACYP3A4ALOX15 | |
| SCHEMBL16053413 | 0.83 | LMNA (0.39) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL11490212 | 0.83 | LMNA (0.39) | LMNASTAT3CYP3A4ALOX15MEN1 | |
| SCHEMBL2443263 | 0.82 | LMNA (0.40) | LMNASTAT3CYP3A4ALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| US-12350136-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-08 | — | — | US | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| US-11458049-B2 | Absorbent articles including perfume and cyclodextrins | THE PROCTER & GAMBLE COMPANY (US) | 2022-10-04 | — | — | US | claimed |
| EP-2787821-B2 | ANTIMICROBIAL COMPOSITION | UNILEVER GLOBAL IP LTD (GB) | 2021-12-01 | — | — | EP | claimed |
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| US-20180064588-A1 | Absorbent Articles Including Perfume and Cyclodextrins | THE PROCTER & GAMBLE COMPANY | 2018-03-08 | — | — | US | claimed |
| EP-2787821-B1 | ANTIMICROBIAL COMPOSITION | UNILEVER NV (NL) | 2016-08-17 | — | — | EP | claimed |
| US-9320271-B2 | Microbial composition | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-04-26 | — | — | US | claimed |
| US-9307761-B2 | Microbial composition | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-04-12 | — | — | US | claimed |
| WO-2013083579-A2 | MICROBICIDAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| WO-2013083594-A1 | ANTIMICROBIAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| WO-2013083587-A1 | MICROBICIDAL COMPOSITION | UNILEVER N.V. (NL) | 2013-06-13 | — | — | WO | claimed |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | SYMRISE GMBH CO. KG (DE) | 2011-02-24 | — | — | US | claimed |
| WO-2010070501-A2 | PERSONAL CARE COMPOSITION CONTAINING A VOLATILE AND A TERPENE ALCOHOL | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-06-24 | — | — | WO | claimed |
| US-20100150971-A1 | PERSONAL CARE COMPOSITION CONTAINING A VOLATILE AND A TERPENE ALCOHOL | KIMBERLY-CLARK WORLDWIDE, INC. | 2010-06-17 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-5574195-A | HYDROXYLATION OF LIMONENE | Chastain, Doyle E. (US) | 1996-11-12 | — | — | US | claimed |
| US-5294645-A | Using menth-1-en-9-ol to kill bacteria, yeast, and fungi | Chastain, Doyle E. (US) | 1994-03-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | TAS1R2, TAS2R5, TAS2R1 | LMNA 3996/4885STAT3 2445/4885CYP3A4 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.